Literature DB >> 20887155

Gene expression profiling of peripheral blood leukocytes identifies potential novel biomarkers of chronic obstructive pulmonary disease in current and former smokers.

Jeffery S Edmiston1, Kellie J Archer, Mariano J Scian, Andrew R Joyce, Barbara K Zedler, E Lenn Murrelle.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease with associated systemic effects.
OBJECTIVE: To use gene expression microarrays in peripheral blood leukocytes of current and former cigarette smokers to identify differences associated with COPD.
MATERIALS AND METHODS: Random forest modelling and a split-sample case-control approach were used to identify candidate predictors.
RESULTS: We identified 1013 genes and one smoking exposure variable that differentiated current and former smokers with or without COPD. This predictor set was reduced to a nine-gene classifier (IL6R, CCR2, PPP2CB, RASSF2, WTAP, DNTTIP2, GDAP1, LIPE and RPL14).
CONCLUSION: These gene expression profiles represent potential biomarkers for COPD and may help increase mechanistic understanding of the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20887155     DOI: 10.3109/1354750X.2010.512091

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  13 in total

1.  The Effect of Different Case Definitions of Current Smoking on the Discovery of Smoking-Related Blood Gene Expression Signatures in Chronic Obstructive Pulmonary Disease.

Authors:  Ma'en Obeidat; Xiaoting Ding; Nick Fishbane; Zsuzsanna Hollander; Raymond T Ng; Bruce McManus; Scott J Tebbutt; Bruce E Miller; Stephen Rennard; Peter D Paré; Don D Sin
Journal:  Nicotine Tob Res       Date:  2016-05-06       Impact factor: 4.244

2.  Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease.

Authors:  Timothy M Bahr; Grant J Hughes; Michael Armstrong; Rick Reisdorph; Christopher D Coldren; Michael G Edwards; Christina Schnell; Ross Kedl; Daniel J LaFlamme; Nichole Reisdorph; Katerina J Kechris; Russell P Bowler
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

Review 3.  Integrative genomics of chronic obstructive pulmonary disease.

Authors:  Brian D Hobbs; Craig P Hersh
Journal:  Biochem Biophys Res Commun       Date:  2014-07-29       Impact factor: 3.575

4.  Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.

Authors:  Li Peng; Xiu Wu Bian; Di Kang Li; Chuan Xu; Guang Ming Wang; Qing You Xia; Qing Xiong
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

5.  Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency.

Authors:  Chiara Rigobello; Simonetta Baraldo; Mariaenrica Tinè; Ilaria Ferrarotti; Angelo Guido Corsico; Erica Bazzan; Graziella Turato; Elisabetta Balestro; Davide Biondini; Giorgio Valle; Marina Saetta; Manuel G Cosio
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

6.  ADAM17 and EGFR regulate IL-6 receptor and amphiregulin mRNA expression and release in cigarette smoke-exposed primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD).

Authors:  Marta Stolarczyk; Gimano D Amatngalim; Xiao Yu; Mieke Veltman; Pieter S Hiemstra; Bob J Scholte
Journal:  Physiol Rep       Date:  2016-08

7.  Predicting treatable traits for long-acting bronchodilators in patients with stable COPD.

Authors:  Jieun Kang; Ki Tae Kim; Ji-Hyun Lee; Eun Kyung Kim; Tae-Hyung Kim; Kwang Ha Yoo; Jae Seung Lee; Woo Jin Kim; Ju Han Kim; Yeon-Mok Oh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-12

Review 8.  The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.

Authors:  Marta Stolarczyk; Bob J Scholte
Journal:  Mediators Inflamm       Date:  2018-01-09       Impact factor: 4.711

9.  An Expert Diagnostic System to Automatically Identify Asthma and Chronic Obstructive Pulmonary Disease in Clinical Settings.

Authors:  Almir Badnjevic; Lejla Gurbeta; Eddie Custovic
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

10.  Meta-analysis of peripheral blood gene expression modules for COPD phenotypes.

Authors:  Dominik Reinhold; Jarrett D Morrow; Sean Jacobson; Junxiao Hu; Benjamin Ringel; Max A Seibold; Craig P Hersh; Katerina J Kechris; Russell P Bowler
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.